These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28588323)

  • 1. Impact of body mass index on ovarian cancer survival varies by stage.
    Bandera EV; Lee VS; Qin B; Rodriguez-Rodriguez L; Powell CB; Kushi LH
    Br J Cancer; 2017 Jul; 117(2):282-289. PubMed ID: 28588323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
    Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
    JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of body weight on ovarian cancer outcomes.
    Backes FJ; Nagel CI; Bussewitz E; Donner J; Hade E; Salani R
    Int J Gynecol Cancer; 2011 Dec; 21(9):1601-5. PubMed ID: 21997171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of the preoperative level of CA125 at presentation of ovarian cancer.
    Cramer DW; Vitonis AF; Welch WR; Terry KL; Goodman A; Rueda BR; Berkowitz RS
    Gynecol Oncol; 2010 Dec; 119(3):462-8. PubMed ID: 20850174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index in relation to ovarian cancer survival.
    Zhang M; Xie X; Lee AH; Binns CW; Holman CD
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1307-10. PubMed ID: 15894691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.
    Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ
    Cancer; 2017 Jul; 123(13):2535-2542. PubMed ID: 28295245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams.
    Kroenke CH; Neugebauer R; Meyerhardt J; Prado CM; Weltzien E; Kwan ML; Xiao J; Caan BJ
    JAMA Oncol; 2016 Sep; 2(9):1137-45. PubMed ID: 27196302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of obesity on secondary cytoreductive surgery and overall survival in women with recurrent ovarian cancer.
    Tran AQ; Cohen JG; Li AJ
    Gynecol Oncol; 2015 Aug; 138(2):263-6. PubMed ID: 26037901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium.
    Minlikeeva AN; Cannioto R; Jensen A; Kjaer SK; Jordan SJ; Diergaarde B; Szender JB; Odunsi K; Almohanna H; Mayor P; Starbuck K; Zsiros E; Bandera EV; Cramer DW; Doherty JA; DeFazio A; ; Edwards R; Goode EL; Goodman MT; Høgdall E; Matsuo K; Mizuno M; Nagle CM; Ness RB; Paddock LE; Pearce CL; Risch HA; Rossing MA; Terry KL; Wu AH; Modugno F; Webb PM; Moysich KB;
    Cancer Causes Control; 2019 May; 30(5):537-547. PubMed ID: 30905014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS).
    Au-Yeung G; Webb PM; DeFazio A; Fereday S; Bressel M; Mileshkin L
    Gynecol Oncol; 2014 Apr; 133(1):16-22. PubMed ID: 24680586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative.
    Simon MS; Hastert TA; Barac A; Banack HR; Caan BJ; Chlebowski RT; Foraker R; Hovsepyan G; Liu S; Luo J; Manson JE; Neuhouser ML; Okwuosa TM; Pan K; Qi L; Ruterbusch JJ; Shadyab AH; Thomson CA; Wactawski-Wende J; Waheed N; Beebe-Dimmer JL
    Cancer; 2021 Feb; 127(4):598-608. PubMed ID: 33151547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
    Morales-Vásquez F; Pedernera E; Reynaga-Obregón J; López-Basave HN; Gómora MJ; Carlón E; Cárdenas S; Silva-Ayala R; Almaraz M; Méndez C
    J Ovarian Res; 2016 Jul; 9(1):41. PubMed ID: 27388275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of body mass index and effect of overweight and obesity on surgical and adjuvant treatment in early-stage epithelial ovarian cancer.
    Skírnisdóttir I; Sorbe B
    Int J Gynecol Cancer; 2008; 18(2):345-51. PubMed ID: 17587318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population.
    Meyerhardt JA; Kroenke CH; Prado CM; Kwan ML; Castillo A; Weltzien E; Cespedes Feliciano EM; Xiao J; Caan BJ
    Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):30-37. PubMed ID: 27986654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and prostate cancer screening, incidence, and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Hurwitz LM; Dogbe N; Barry KH; Koutros S; Berndt SI
    J Natl Cancer Inst; 2023 Dec; 115(12):1506-1514. PubMed ID: 37382561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer.
    Dignam JJ; Wieand K; Johnson KA; Raich P; Anderson SJ; Somkin C; Wickerham DL
    Breast Cancer Res Treat; 2006 Jun; 97(3):245-54. PubMed ID: 16331345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women's Health Initiative.
    Zhou Y; Chlebowski R; LaMonte MJ; Bea JW; Qi L; Wallace R; Lavasani S; Walsh BW; Anderson G; Vitolins M; Sarto G; Irwin ML
    Gynecol Oncol; 2014 Apr; 133(1):4-10. PubMed ID: 24680584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer.
    Kjaerbye-Thygesen A; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):798-803. PubMed ID: 16614126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.